Through an ISHLT mailing, 210 centers identified a representative to complete the survey managed by the Research Survey Center at Mayo Clinic. Data regarding pre, peri, and post-implantation practices was collected. Representatives from 56 centers have completed the survey by November 2012. 37 (...
DG Maki,DM Kluger,CJ Crnich - 《Mayo Clinic Proceedings Mayo Clinic》 被引量: 1837发表: 2006年 Infection control in the ICU. Nosocomial infections (NIs) now concern 5 to 15% of hospitalized patients and can lead to complications in 25 to 33% of those patients admitted to ICUs. Th......
Infect Control Hosp Epidemiol. 2010;31(5):431–55. Article PubMed Google Scholar Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl...
Ashley ZhouMayo ClinicUnited States Nadine Bacalangco SuerteWest Visayas State University Medical CenterPhilippines Day 1: Speakers in Poster Category (In Person): Silvia Giono CerezoSilvia Giono Cerezo ENCB Instituto Politecnico NacionalMexico
by Laurel Kelly,Mayo Clinic A medical illustration of Clostridioides difficile bacteria, formerly known as Clostridium difficile, presented in the Centers for Disease Control and Prevention (CDC) publication entitled, Antibiotic Resistance Threats in the United States, 2019. Credit: CDC ...
On the other hand, it is important to control the doses of corticosteroids, as there is no specific evidence suggest high-dose treatments are effective. Baricitinib Baricitinib, a drug used for treating rheumatoid arthritis (RA), can reduce viral entry and inflammation. Baricitinib is an ...
Infect Control Hosp Epidemiol 2000;21:718-723. 5. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28:123-130. Bios Photo key: from ...
We focus on infection control, particularly active screening, use of contact precautions as well as pharmacologic options for therapy. This is timely given the evolving priorities in efforts towards the prevention and treatment of multidrug-resistant organisms globally. Key findings include new data ...
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16(7):828–37. Article CAS Google Scholar Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, et al. Histoplasmosis after solid organ transplant. Clin Infect...
gastric tube inserting,the use of hormone.But it doesn't have a close connection with age or gender.The prime pathogenic bacteria is Conidial Albican.Conclusion:Patients of manmade trachea are easy to get lung infection,so we should take precaution,control as well as reduce the ratio of the...